Santa Clara, United States
Verix is an innovative company offering an AI-powered Commercial Optimization Platform, tailored to enhance the performance and revenue of pharmaceutical brands. With a specific focus on pharma commercial operations, Verix provides a unique, cloud-based suite of analytic applications, serving a multitude of daily users from Fortune 500 companies.
Founded in 2007, Verix operates within the intersecting industries of AI, Analytics, Life Sciences, and SaaS. Headquartered in the United States, the company has established itself as a trusted resource for identifying high-return opportunities and facilitating profitable growth amid the dynamics of the business environment.
Investors may find the company's growth trajectory promising, particularly following its last investment, a $12.70M Series B funding, supported on 12 February 2006 by Gemini Israel Ventures, Viola Ventures, and Hillsven Capital. As a forward-looking entity, Verix positions itself as a catalyst for revenue optimization in the pharmaceutical sector.
